Syndax Pharmaceuticals (SNDX) Change in Inventory (2024 - 2026)

Syndax Pharmaceuticals' Change in Inventory history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• On a quarterly basis, Change in Inventory fell 50.85% year-over-year to $2.1 million in Q1 2026; TTM through Mar 2026 was $30.0 million, a 557.45% increase from a year earlier, with the FY2025 full-year figure at $32.1 million, up 8668.03% from the prior year.
• Change in Inventory eased to $2.1 million in Q1 2026 per SNDX's latest filing, from $7.8 million in the prior quarter.
• Across five years, Change in Inventory topped out at $12.9 million in Q2 2025 and bottomed at $366000.0 in Q4 2024.
• The 3-year median for Change in Inventory is $5.7 million (2025), against an average of $5.8 million.
• Across the five-year window, Change in Inventory jumped 2031.42% in 2025 and tumbled 50.85% in 2026, its largest moves.
• Year by year, Change in Inventory stood at $366000.0 in 2024, then soared by 2031.42% to $7.8 million in 2025, then plunged by 73.59% to $2.1 million in 2026.
• Per Business Quant, the three latest SNDX Change in Inventory figures stand at $2.1 million (Q1 2026), $7.8 million (Q4 2025), and $7.2 million (Q3 2025).